Home Featured Page 227

Featured

Latest

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and...

MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results

Filament Health Announces Q2 2021 Financial Results

PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of...

In Awe: Psychedelic Assisted Psychotherapy and the Mystical Experience

Myth Busting: Magic Mushroom Spores Have Little to do with Potency

Why Aren’t Psychedelic Drugs Prohibited in the 2021 Tokyo Olympics?

Enzymes Responsible for DMT Synthesis Coexist in Mammalian Brain Cells

1...226227228...299 Page 227 of 299

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

Book Club – Trip Sitting

Book Club! Built To Burn: Tales of the Desert Carnies of Burning Man

Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and...

MindMed Joins Critical Path Institute’s Patient-Reported Outcome Consortium

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results

Filament Health Announces Q2 2021 Financial Results

PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of...

In Awe: Psychedelic Assisted Psychotherapy and the Mystical Experience

Myth Busting: Magic Mushroom Spores Have Little to do with Potency

Why Aren’t Psychedelic Drugs Prohibited in the 2021 Tokyo Olympics?

Enzymes Responsible for DMT Synthesis Coexist in Mammalian Brain Cells

EDITOR PICKS

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Solidarity Fridays – Joe Moore and Kyle Buller

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY